By Jamie D. Weisman, MD
New treatments, personalized care are just some of the exciting advancements to come To understand the future of dermatologic therapies, we need to understand where we have been. The biologic revolution in the treatment of dermatologic disease began in January 2002, when the tumor necrosis factor receptor blocker etanercept (Enbrel) was approved for the treatment of ... Continue Reading
By Jason A. Clark, MD, FAAD
The health effects of light on the skin are well known. Ultraviolet (UV) light causes DNA damage and precancerous growths and is the primary risk factor for most skin cancers. As much as 80% of skin aging is thought to result from sun exposure.1 On the other hand, UV light exerts anti-inflammatory, immunomodulatory effects that have been exploited for decades in office and ... Continue Reading
By Melinda R. Mohr, MD
The gold standard for melanoma diagnosis is routine histopathology with hematoxylin and eosin (H&E) stains. For clear-cut cases of melanoma, this alone is sufficient. However, as in all things in medicine, there are cases that fall within the gray zone. Is it an atypical nevus or is it melanoma? This is a question encountered on a daily basis in the practice of ... Continue Reading
By Jamie Weisman, MD
In 2002, the FDA approved etanercept (Enbrel) for the treatment of psoriatic arthritis. The next year, alefacept (Amevive) and efalizumab (Raptiva) were approved for plaque psoriasis, followed by etanercept in 2006 and adalimumab (Humira) in 2008. The completion of my dermatology residency at Emory University in 2002 coincided with the introduction of these drugs. Emory’s ... Continue Reading
By Helen Selser, M.D. From ATLANTA Medicine, Vol. 85, No. 5 With an estimated 35 million cases each year, Onychomycosis (fungal infection of the nail unit) is one of the most common dermatological problems in the United States. While oral medications carry risks and often do not produce a lasting cure, new topical medications provide viable monotherapy ... Continue Reading
By Asha R. Patel, M.D. From ATLANTA Medicine, Vol. 85, No. 5 While primarily thought of as an outpatient specialty, the practice of dermatology also plays a vital role in certain hospital settings. By providing assistance for an efficient assessment, application of diagnostic studies and suggestion of treatment plans for cutaneous disease, the dermatologist can be a ... Continue Reading
